Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 1:13 pm Sale | 13G | Silence Therapeutics plc SLN | Lombard Odier Asset Management (USA) Corp | 7,992,231 5.700% | -3,645,288 (-31.32%) | View |
| 2024-02-14 09:54 am Purchase | 13G | Silence Therapeutics plc SLN | Lombard Odier Asset Management (USA) Corp | 11,637,519 10.400% | 10,317 (+0.09%) | View |
| 2023-02-14 10:45 am Purchase | 13G | Silence Therapeutics plc SLN | Lombard Odier Asset Management (USA) Corp | 11,627,202 10.800% | 1,209,639 (+11.61%) | View |
| 2022-02-10 4:44 pm Sale | 13G | Silence Therapeutics plc SLN | Lombard Odier Asset Management (USA) Corp | 10,417,563 11.600% | -503,008 (-4.61%) | View |
| 2021-02-12 6:02 pm Purchase | 13G | Silence Therapeutics plc SLN | Lombard Odier Asset Management (USA) Corp | 10,920,571 12.200% | 10,920,571 (New Position) | View |